Alternatives to alirocumab
1 same-class SPL records vs alirocumab - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.
Brand: Praluent
About alirocumab
Praluent is a medicine that can lower cholesterol. It can also lower the risk of heart problems like heart attack or stroke in some adults.
Used for: Praluent is used to lower LDL cholesterol (bad cholesterol). It is used along with diet and exercise in adults with high cholesterol. It is also used in adults and children 8 years and older who have a genetic condition that causes high cholesterol.
1 PCSK9 Inhibitor peers (wide set)
alirocumab vs evolocumab · FAERS reaction fields
FAERS top-reaction field "Injection Site Pain" shows the widest count spread between alirocumab and evolocumab in this extract (9,062-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.
| Side Effect | alirocumab | evolocumab |
|---|---|---|
| Myalgia | 1,655 | 5,267 |
| Product Dose Omission | 1,364 | - |
| Injection Site Pain | 1,278 | 10,340 |
| Muscle Spasms | 1,162 | 3,171 |
| Arthralgia | 1,053 | 3,922 |
| Fatigue | 1,018 | 3,872 |
| Pain | 945 | 2,973 |
| Pain In Extremity | 935 | 3,373 |
"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.
alirocumab peer mix vs class inventory
Peer mix
0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for PCSK9 Inhibitor: 2 drugs.
Frequently Asked Questions
What same-class SPL records sit beside alirocumab? ▼
Reading a wide PCSK9 Inhibitor peer set (1 records)
alirocumab (Praluent) sits in a wide PCSK9 Inhibitor peer set (1 of 1 class peers shown). Labeled indication field for alirocumab: Praluent is used to lower LDL cholesterol (bad cholesterol).
Top FAERS reaction fields for alirocumab total 11,050 reports across 10 reactions, set beside evolocumab. Counts are exposure-weighted submissions, not per-patient risk.
Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.
Field note for alirocumab: see also the generic vs brand label guide when reading Praluent SPL strings.
Read our methodology - how this data is sourced, computed, and verified.